Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
2.331
+0.051 (2.24%)
May 27, 2025, 3:29 PM - Market open
Vivos Therapeutics Market Cap
Vivos Therapeutics has a market cap or net worth of $13.73 million as of May 27, 2025. Its market cap has increased by 93.83% in one year.
Market Cap
13.73M
Enterprise Value
12.49M
1-Year Change
93.83%
Ranking
Category
Stock Price
$2.33
Market Cap Chart
Since the IPO on December 11, 2020, Vivos Therapeutics's market cap has decreased from $103.52M to $13.73M, a decrease of -86.74%. That is a compound annual growth rate of -36.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 23, 2025 | 13.43M | -46.85% |
| Dec 31, 2024 | 25.27M | 69.64% |
| Dec 29, 2023 | 14.89M | 61.00% |
| Dec 30, 2022 | 9.25M | -82.13% |
| Dec 31, 2021 | 51.78M | -50.41% |
| Dec 31, 2020 | 104.41M | 0.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 640.72B |
| Johnson & Johnson | 367.98B |
| AbbVie | 323.71B |
| Novo Nordisk | 298.78B |
| UnitedHealth Group | 268.12B |
| Abbott Laboratories | 228.44B |
| Novartis AG | 221.01B |
| AstraZeneca | 218.42B |